Orphan Therapies LLC

1 FDA products 1 active ingredients HUMAN PRESCRIPTION DRUG

Orphan Therapies LLC is listed as the manufacturer on 1 FDA drug label records covering 1 distinct active ingredients predominantly human prescription drug products.

About Orphan Therapies LLC

Orphan Therapies LLC is named as the labeler on 1 FDA drug label records. Its catalogue spans 1 distinct active ingredients, led by ETUVETIDIGENE AUTOTEMCEL. Most of these labels are human prescription drug products. Labelling across this portfolio most often references: hematopoietic stem, treatment pediatric, patients aged, wiskott-aldrich syndrome, cell transplantation, hsct appropriate, suitable human, leukocyte antigen. Use the table below to identify a specific product, then open it for full indications, dosage and warnings as filed with the FDA.

Active ingredients in this portfolio

Active ingredientProducts
ETUVETIDIGENE AUTOTEMCEL 1

Dosage forms and routes

Dosage formProductsRouteProducts
— — INTRAVENOUS 1
— — — —
— — — —
— — — —
— — — —
— — — —

FDA drug products from Orphan Therapies LLC

Brand nameGenericTypeRoute
WASKYRA ETUVETIDIGENE AUTOTEMCEL HUMAN PRESCRIPTION DRUG INTRAVENOUS

Frequently asked questions

How many FDA drug products does Orphan Therapies LLC make?
1 FDA drug label records name Orphan Therapies LLC as the manufacturer, covering 1 distinct active ingredients.

What active ingredients does Orphan Therapies LLC produce?
The most frequent active ingredients in this portfolio are ETUVETIDIGENE AUTOTEMCEL.

Are Orphan Therapies LLC products prescription or over-the-counter?
The largest share of this company’s labels are human prescription drug products; check each product page for its own marketing status.

Does this page list prices or where to buy?
No. This is a labelling reference built from FDA data. It does not sell, price or recommend any medicine.

Labelling data reproduced from FDA Structured Product Labelling for identification only. This site does not sell, price or recommend any medicine.